Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children.

Trial Profile

Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Dec 2014

At a glance

  • Drugs JEVAC inactivated Japanese encephalitis vaccine (vero cell) (Primary)
  • Indications Japanese encephalitis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 17 Nov 2014 Status of the trial changed from active no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 09 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top